Maglasang, Zacarias L.
HRN: 25-89-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/14/2024
09/21/2024
IV
500 Mg
8hrs
Indirect Inguinal Hernia Irreducible
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes